收藏切换
Preliminary considerations on optimizing the dispute resolution path of drug registration procedure
收藏切换
Jian LU1, Tan-lin SUN2, Yu BAI1, *
Chinese Journal of New Drugs | 2026, 35(14) : 1498 - 1501
Less
收藏切换
Chinese Journal of New Drugs | 2026, 35(14): 1498-1501
Preliminary considerations on optimizing the dispute resolution path of drug registration procedure
Full
Jian LU1, Tan-lin SUN2, Yu BAI1, *
Affiliations
  • 1Center for Drug Evaluation, National Medical Products Administration, Beijing 100163, China
  • 2National Medical Products Administration Institute of Executive Development, Beijing 100073, China
Published: 2026-07-30 doi: 10.20251/j.cnki.1003-3734.2026.14.007
Outline
收藏切换

The legality and certainty of administrative licensing for drug registration are core symbols of the modernization of the country's drug regulatory system. In the context of multiple links and departments participating in drug registration, it is particularly important to balance the right to statement and defense of drug registration applicants with the maintenance of administrative efficiency. This paper sorted out the dispute resolution mechanisms involved in the current drug registration process, analyzed the ambiguous areas in procedure connection and determination of the effect of conclusions, as well as the challenges they pose to the scientificity and authority of administrative licensing decisions. It also proposed preliminary suggestions to improve China's drug registration dispute resolution mechanism from the legislative, institutional and procedural levels, aiming to provide references for building a drug registration dispute resolution mechanism with clear power and responsibilities, fair procedures, smooth connection and efficient operation.

drug registration  /  dispute resolution  /  administrative rights  /  due legal process  /  procedural justice  /  administrative efficiency
陆建, 孙潭霖, 白玉. 药品注册程序中争议解决机制优化的初步考虑. 中国新药杂志, 2026 , 35 (14) : 1498 -1501 . DOI: 10.20251/j.cnki.1003-3734.2026.14.007
Jian LU, Tan-lin SUN, Yu BAI. Preliminary considerations on optimizing the dispute resolution path of drug registration procedure[J]. Chinese Journal of New Drugs, 2026 , 35 (14) : 1498 -1501 . DOI: 10.20251/j.cnki.1003-3734.2026.14.007
Year 2026 volume 35 Issue 14
41
8
Cite this Article
BibTeX
Article Info
doi: 10.20251/j.cnki.1003-3734.2026.14.007
  • Online Date:2026-10-26
  • Published:2026-07-30
Article Data
Affiliations
History
  • Accepted:2025-10-13
Affiliations
    1Center for Drug Evaluation, National Medical Products Administration, Beijing 100163, China
    2National Medical Products Administration Institute of Executive Development, Beijing 100073, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/10.20251/j.cnki.1003-3734.2026.14.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT